Pharmafile Logo

Rob Jones

- PMLiVE

Access – the only thing that matters

Our job, at its very core, is to get our medicines into the hands of patients

Blog: Affordable Care Act

What does the future hold for the US pharma industry?

Inizio

- PMLiVE

PD-1 cancer market overrated, says new report

The immuno-oncology market for new oncology drugs may be worth half of current expectations

- PMLiVE

Merck adds another immuno-oncology tie-up

Firm to test Keytruda with Syndax’s entinostat in melanoma and NSCLC

- PMLiVE

Amgen gets quick US review for Kyprolis

To be considered as a second-line therapy for multiple myeloma

- PMLiVE

Bowel Cancer UK launches research initiative

Announcement for its R&D commitment comes during Bowel Cancer Awareness Month

- PMLiVE

UCB and MRC join forces on novel antibody discovery platform

Will provide UK scientists with access to up-to-date technologies

- PMLiVE

PRC Clinical makes key management appointments

And launches operation in the East Coast of the US

- PMLiVE

Ogilvy CommonHealth releases pharmacy report

The Power of Pharmacy debates its role and the change it faces

- PMLiVE

The art and science of local KOLs

Marketers can stay ahead of the curve with regional knowledge

NHS to expand video and email consultation pilots

Move is part of plans to increase patient access to GPs and pharmacists

- PMLiVE

Start me up: The virtue of patience

Regardless of an agency's size, the hardest lesson to learn is that of being patient

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links